Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 14Rectal Neoplasms 13Colonic Neoplasms 10Esophageal Neoplasms 5Stomach Neoplasms 4Rhabdomyosarcoma 4Pancreatic Neoplasms 4Neuroblastoma 4Central Nervous System Neoplasms 4Adenocarcinoma Of Esophagus 4Sarcoma 3Neoplasm Metastasis 3Medulloblastoma 3Lung Neoplasms 3Wilms Tumor 2Unspecified Childhood Solid Tumor, Protocol Specific 2Sarcoma, Ewing 2Ovarian Neoplasms 2Optic Nerve Glioma 2Oligodendroglioma 2Malignant mesenchymal tumor 2Fibrolamellar hepatocellular carcinoma 2Familial ependymoma 2Esophageal Squamous Cell Carcinoma 2Choroid Plexus Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Paclitaxel 27Carboplatin 23Cisplatin 16Topotecan 8Taxes 8Docetaxel 7Gemcitabine 6Filgrastim 5Etoposide 4Doxorubicin 4Cyclophosphamide 4Psychiatric Rehabilitation 3Ifosfamide 3Chemotherapy, Adjuvant 3rubitecan 2pegfilgrastim 2paclitaxel poliglumex 2liposomal doxorubicin 2Trabectedin 2Surgical Procedures, Operative 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Irinotecan 2GEN-1 2Fenretinide 2Erlotinib Hydrochloride 2Drug Therapy 2Celecoxib 2Bevacizumab 2Amifostine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Ovarian Neoplasms × Irinotecan × Clear all
NCT01941316 2024-05-09

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Cancer Research and Biostatistics Clinical Trials Consortium

Phase 1/2 Completed
78 enrolled 15 charts
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT00053833 2013-11-08

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

SWOG Cancer Research Network

Phase 2 Terminated
2 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡